ADDvise Group AB (publ) (ADDV-A.ST)
SEK 11.2
(1.36%)
SEK 11.2
(1.36%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 300.6 Million SEK | -47.72% |
| 2022 | 575.01 Million SEK | 165.52% |
| 2021 | 216.56 Million SEK | 56.82% |
| 2020 | 138.1 Million SEK | 0.98% |
| 2019 | 136.76 Million SEK | 21.6% |
| 2018 | 112.47 Million SEK | 11.19% |
| 2017 | 101.15 Million SEK | 26.9% |
| 2016 | 79.7 Million SEK | 19.67% |
| 2015 | 66.6 Million SEK | 6.7% |
| 2014 | 62.41 Million SEK | 23.39% |
| 2013 | 50.58 Million SEK | 16.79% |
| 2012 | 43.31 Million SEK | 141.5% |
| 2011 | 17.93 Million SEK | 134.06% |
| 2010 | 7.66 Million SEK | 0.0% |
| 2009 | - SEK | -100.0% |
| 2008 | 11.16 Million SEK | -1.33% |
| 2007 | 11.31 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 64.2 Million SEK | -15.19% |
| 2024 Q2 | 57.8 Million SEK | -9.97% |
| 2024 Q3 | 212 Million SEK | 266.78% |
| 2023 Q2 | 235.6 Million SEK | 241.45% |
| 2023 Q3 | 210.8 Million SEK | -10.53% |
| 2023 FY | 300.6 Million SEK | -47.72% |
| 2023 Q4 | 75.7 Million SEK | -64.09% |
| 2023 Q1 | 69 Million SEK | -67.02% |
| 2022 FY | 575.01 Million SEK | 165.52% |
| 2022 Q1 | 87.3 Million SEK | 22.38% |
| 2022 Q2 | 141.1 Million SEK | 61.63% |
| 2022 Q3 | 137.36 Million SEK | -2.66% |
| 2022 Q4 | 209.24 Million SEK | 52.33% |
| 2021 FY | 216.56 Million SEK | 56.82% |
| 2021 Q1 | 38.09 Million SEK | -0.81% |
| 2021 Q2 | 52.69 Million SEK | 38.34% |
| 2021 Q3 | 54.44 Million SEK | 3.31% |
| 2021 Q4 | 71.33 Million SEK | 31.03% |
| 2020 FY | 138.1 Million SEK | 0.98% |
| 2020 Q2 | 38.98 Million SEK | 18.44% |
| 2020 Q1 | 32.92 Million SEK | -11.32% |
| 2020 Q4 | 38.4 Million SEK | 38.2% |
| 2020 Q3 | 27.78 Million SEK | -28.73% |
| 2019 Q3 | 31.06 Million SEK | -16.86% |
| 2019 FY | 136.76 Million SEK | 21.6% |
| 2019 Q1 | 31.2 Million SEK | -0.87% |
| 2019 Q2 | 37.36 Million SEK | 19.73% |
| 2019 Q4 | 37.12 Million SEK | 19.49% |
| 2018 Q2 | 28 Million SEK | -0.78% |
| 2018 Q4 | 31.48 Million SEK | 27.12% |
| 2018 FY | 112.47 Million SEK | 11.19% |
| 2018 Q1 | 28.22 Million SEK | -2.79% |
| 2018 Q3 | 24.76 Million SEK | -11.55% |
| 2017 Q2 | 28.62 Million SEK | 19.39% |
| 2017 FY | 101.15 Million SEK | 26.9% |
| 2017 Q4 | 29.03 Million SEK | 48.68% |
| 2017 Q3 | 19.52 Million SEK | -31.77% |
| 2017 Q1 | 23.97 Million SEK | 11.55% |
| 2016 FY | 79.7 Million SEK | 19.67% |
| 2016 Q3 | 17.35 Million SEK | -22.55% |
| 2016 Q4 | 21.49 Million SEK | 23.8% |
| 2016 Q2 | 22.41 Million SEK | 21.49% |
| 2016 Q1 | 18.44 Million SEK | 15.39% |
| 2015 FY | 66.6 Million SEK | 6.7% |
| 2015 Q1 | 18.81 Million SEK | 2.75% |
| 2015 Q2 | 16.87 Million SEK | -10.3% |
| 2015 Q3 | 14.92 Million SEK | -11.59% |
| 2015 Q4 | 15.98 Million SEK | 7.14% |
| 2014 Q4 | 18.31 Million SEK | 41.81% |
| 2014 Q1 | 16 Million SEK | 25.29% |
| 2014 Q2 | 15.18 Million SEK | -5.08% |
| 2014 Q3 | 12.91 Million SEK | -14.98% |
| 2014 FY | 62.41 Million SEK | 23.39% |
| 2013 Q4 | 12.77 Million SEK | 5.35% |
| 2013 FY | 50.58 Million SEK | 16.79% |
| 2013 Q1 | 11.72 Million SEK | -16.29% |
| 2013 Q2 | 13.96 Million SEK | 19.09% |
| 2013 Q3 | 12.12 Million SEK | -13.2% |
| 2012 Q3 | 9.26 Million SEK | -18.03% |
| 2012 Q1 | 8.85 Million SEK | 72.44% |
| 2012 Q2 | 11.3 Million SEK | 27.68% |
| 2012 Q4 | 14 Million SEK | 51.15% |
| 2012 FY | 43.31 Million SEK | 141.5% |
| 2011 FY | 17.93 Million SEK | 134.06% |
| 2011 Q3 | 4.43 Million SEK | -13.69% |
| 2011 Q4 | 5.13 Million SEK | 15.73% |
| 2011 Q1 | 3.51 Million SEK | -17.35% |
| 2011 Q2 | 5.14 Million SEK | 46.22% |
| 2010 FY | 7.66 Million SEK | 0.0% |
| 2010 Q4 | 4.25 Million SEK | 585.02% |
| 2010 Q3 | 621 Thousand SEK | -61.11% |
| 2010 Q2 | 1.59 Million SEK | 34.09% |
| 2010 Q1 | 1.19 Million SEK | 0.0% |
| 2009 Q4 | - SEK | 0.0% |
| 2009 FY | - SEK | -100.0% |
| 2009 Q2 | 3.37 Million SEK | 21.66% |
| 2009 Q1 | 2.77 Million SEK | -3.48% |
| 2009 Q3 | - SEK | -100.0% |
| 2008 FY | 11.16 Million SEK | -1.33% |
| 2008 Q1 | 3.15 Million SEK | 8.27% |
| 2008 Q2 | 2.45 Million SEK | -22.18% |
| 2008 Q4 | 2.87 Million SEK | 0.0% |
| 2007 Q4 | 2.91 Million SEK | 0.0% |
| 2007 FY | 11.31 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acarix AB (publ) | 5.29 Million SEK | -5574.91% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 0.0% |
| Arcoma AB | 11.07 Million SEK | -2615.202% |
| Bactiguard Holding AB (publ) | 139.98 Million SEK | -114.743% |
| BICO Group AB (publ) | 1.83 Billion SEK | 83.579% |
| Boule Diagnostics AB (publ) | 249.71 Million SEK | -20.378% |
| CellaVision AB (publ) | 463.04 Million SEK | 35.081% |
| Clinical Laserthermia Systems AB (publ) | 2.99 Million SEK | -9930.03% |
| Chordate Medical Holding AB (publ) | -28.41 Million SEK | 1157.926% |
| C-Rad AB (publ) | 66.01 Million SEK | -355.351% |
| Duearity AB (publ) | -4.17 Million SEK | 7294.83% |
| Dignitana AB (publ) | 58.97 Million SEK | -409.742% |
| Episurf Medical AB (publ) | -41.8 Million SEK | 819.139% |
| Getinge AB (publ) | 13.43 Billion SEK | 97.762% |
| Scandinavian Real Heart AB (Publ) | -50.21 Million SEK | 698.598% |
| Iconovo AB (publ) | 17.57 Million SEK | -1610.126% |
| Integrum AB (publ) | 690.56 Thousand SEK | -43429.763% |
| Luxbright AB (publ) | -2.79 Million SEK | 10847.706% |
| Mentice AB (publ) | 236.38 Million SEK | -27.168% |
| OssDsign AB (publ) | 83.64 Million SEK | -259.376% |
| Paxman AB (publ) | 12.61 Million SEK | -2282.311% |
| Promimic AB (publ) | 38.51 Million SEK | -680.475% |
| Qlife Holding AB (publ) | -50.75 Million SEK | 692.28% |
| SciBase Holding AB (publ) | 16.03 Million SEK | -1774.415% |
| ScandiDos AB (publ) | 47.55 Million SEK | -532.11% |
| Sectra AB (publ) | 557.55 Million SEK | 46.086% |
| Sedana Medical AB (publ) | 108.98 Million SEK | -175.828% |
| Senzime AB (publ) | 8.33 Million SEK | -3504.749% |
| SpectraCure AB (publ) | -9.22 Million SEK | 3359.243% |
| Stille AB | 132.17 Million SEK | -127.433% |
| Vitrolife AB (publ) | 1.97 Billion SEK | 84.803% |
| Xvivo Perfusion AB (publ) | 416.91 Million SEK | 27.899% |